Autologous hematopoietic stem cell transplant at experienced centers in the current era can include indefinite disease ...

Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown that the commonly used high-cholesterol drug simvastatin cannot slow ...

A cross-section of the spinal cord showing neurons and glial cells. (Juan Carlos Juarez Jaramillo/iStock/Getty Images Plus) A ...

The MSAA is expanding its patient-centered research network to include more than 1,000 people with MS receiving care at 20 ...

An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis on Saturday won a prestigious Breakthrough Prize, the award nicknamed the "Oscars of ...

A new multiple sclerosis (MS) research project designed to help the brain repair itself by activating its own healing processes has been announced as part of MS Australia's latest $5.7 million ...

Black people with multiple sclerosis (MS) may face higher mortality rates and more severe symptoms than white people, yet 98% of participants in recent MS drug trials were white. This lack of ...

NEW YORK--(BUSINESS WIRE)--The Tisch MS Research Center of New York, the world’s largest independent research center focused on MS, today announced the Phase II results of its FDA-approved stem cell ...

VIRGINIA BEACH, Va. (WAVY) – Thanks to research over the last year, a number of breakthroughs have been made in the world of Multiple Sclerosis. Bruce Bebo, the Executive Vice President of Research ...

A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) has received nearly $800,000 US ($1,137,868 CAD) in new funding to advance ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. March is Multiple Sclerosis Awareness Month, a time to ...